Mark Kawakami - 05 Jul 2024 Form 3 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role: Chief Financial Officer
Signature: Mark Kawakami, by Attorney-in-fact, Solaeta Chan
Issuer symbol: RKDA
Transactions as of: 05 Jul 2024
Net transactions value: $0
Form type: 3
Filing time: 18 Jul 2024, 16:22:02 UTC
Next filing: 20 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RKDA	Common Stock						1,281	05 Jul 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RKDA	Stock Option (Right to Buy)							05 Jul 2024	Common Stock	300	$90.80	Direct	F1
holding	RKDA	Stock Option (Right to Buy)							05 Jul 2024	Common Stock	300	$50.80	Direct	F2
holding	RKDA	Stock Option (Right to Buy)							05 Jul 2024	Common Stock	137	$37.74	Direct	F3
holding	RKDA	Stock Option (Right to Buy)							05 Jul 2024	Common Stock	250	$10.80	Direct	F4
holding	RKDA	Stock Option (Right to Buy)							05 Jul 2024	Common Stock	500	$4.68	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were granted on 9/13/21 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.
F2	The options were granted on 4/11/22 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.
F3	The options will vest annually in equal installments over a period of three years from the date of the grant, 8/16/2022, subject to the Participant's continued service.
F4	The options were granted on 1/1/23 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.
F5	The options were granted on 5/17/23 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.